All News

The discussion about managed care comes as lawmakers continue to ignore pleas to expand Medicaid to 191,000 uninsured residents in Missouri. A White House report released earlier this month made a case for expansion but was largely ignored by expansion opponents.

Researchers at the University of Pennsylvania correlated data from Geographic Information Systems, hospital referral regions, census data, and CDC's State Cancer Profiles, to evaluate whether geographic barriers can prevent access to gynecologic cancer care.

Newly announced fraud charges against 243 individuals involved schemes of approximately $712 million worth in false billings, according to an announcement by HHS. CMS also suspended a number of providers.

A study published in PLOS ONE found that a higher intake of dietary trans fat correlated with memory loss in men 45 years old and younger.

The first year of CMS' Independence at Home Demonstration led to both higher quality care and and saved $25 million, an average of $3070 per participating beneficiary.

Despite the increased use of breast-conserving therapy among women with early-stage breast cancer, many women continue to undergo mastectomy, according to a study from researchers at the University of Texas MD Anderson Cancer Center in Houston published in JAMA Surgery.

Scientists at Institut Pasteur in France have repurposed DPP4 inhibitors, used to treat type 2 diabetes mellitus, to boost the body's immune response to tumors.

While Republicans continue to look at dismantling President Obama's Affordable Care Act, they are also working on plans to extend subsidies temporarily to the millions of Americans who may lose the financial assistance should the Supreme Court rule in favor of the plaintiffs in King v. Burwell.

Concepts from the patient-centered medical home model can offer answers to giving the newly insured a place to find care outside of the emergency department setting.

In its proposed fiscal year 2016 funding bill, the House Appropriations Committee is looking to defund the Affordable Care Act, block additional funding for patient-centered outcomes research, and terminate the Agency for Healthcare Research and Quality.

Read how being denied new technology by my insurance company impacts me.

A report by the American Cancer Society, published in JAMA Internal Medicine, finds smoking significantly increases the risk of cancer-related death.

If the Supreme Court rules that individuals in states on the federal marketplace are ineligible for subsidies, the annual consumer premium contribution could increase $3300 in 2015, according to an analysis from Avalere Health.

The findings of inadequate access to providers and outdated information were no surprise to healthcare advocates. Many of the issues are addressed in a giant proposed rule issued by CMS in late May.

Another 2 companies that are using natural language processing and artificial intelligence in their efforts on direct-to-person health coaching.

Published in the Journal of the American Pharmacists Association, the study found a significant improvement in the blood pressure of T2DM patients who were counseled by a pharmacist.

The consensus that drug manufacturers are at fault for high prescription prices comes even though only half the respondents said they were taking medication themselves.

Although the introduction of new specialty drugs and increased investments into personal health data security, moderating forces will keep healthcare spending growth in check in 2016, according to a report from PwC's Health Research Institute.

Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer.

A paper published in the British Medical Journal, authored by FDA staff, compares content from FDA's complete response letter for a rejected drug, with the subsequent press release by drug developers.

Arkansas, Delaware, and Pennsylvania have all received tentative approval from HHS Secretary Sylvia Mathews Burwell to set up their own state-based insurance exchanges and move their residents off the federally facilitated marketplace.

Aledade, founded by Farzard Mostashari, MD, announced on Monday that it had raised $30 million to support its mission of partnering with independent primary care physicians to create accountable care organizations and further fuel the company's growth.

The availability of dabigatran 110 mg in the US may be a favorable therapeutic option for patients at high risk of bleeding, who may be willing to accept a higher probability of stroke for a reduced risk of hemorrhage

The FDA plans to mine data submitted by patients on the site PatientsLikeMe.

A new policy emerged from the annual meeting of the American Medical Association that calls for increased access to and coverage of integrated medical and behavioral healthcare services for patients.

Robert A. Gabbay, MD, PhD, FACP, chief medical officer at Joslin Diabetes Center, moderates a discussion on the role of combination therapy in several ways, including early aggressive therapy with combination treatment and the combination of taking 2 medications in 1 tablet to encourage adherence with increased convenience and reduced copays. He is joined by S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE; Ravi Retnakaran, MD, MSc, FRCPC; Alexander Turchin, MD, MS; and Helen Feit, MD.

Dennis P. Scanlon, PhD, faculty member and health services researcher at Penn State University, associate editor of The American Journal of Managed Care, moderates a discussion regarding the idea of value as it pertains to the emerging treatments and approaches for diabetes care. He is joined by panelists David Brumley, MD, MBA; Edmund J. Pezalla, MD, MPH; and Michael S. Sherman, MD, MBA, MS.

Om P. Ganda, MD, director, Lipid Clinic, Joslin Diabetes Center, discusses cholesterol and lipidemia as high risk factors for cardiovascular disease (CVD), where diabetes itself is a risk factor for CVD. Dr Ganda refutes the misconception that exposure to cholesterol complications begins for adults 40 years old or over; these complications, he points out, can begin at a very early age depending upon the individual. Individuals can face CVD in their early 20's and 30's due to the cumulative burden of cholesterol.

Howard Wolpert, MD, senior physician in adult diabetes at Joslin Diabetes Center, director of Joslin Institute for Technology Translation, and associate professor at Harvard Medical School, recognizes 3 issues with current care delivery models that with modification, can change diabetes care in this emerging digital health era. These factors, he pointed out, include: a serious lack of diabetes specialists, an unsuccessful acute-based therapeutic model that concentrates on prescriptive dose adjustment, and an unrealistic care delivery model of patient scheduled office visits. Dr Wolpert believes that care models currently in place are not effectively promoting patient engagement, self-care and self-management skills. Further, they do not adequately satisfying the needs of a patient with a chronic disease like diabetes who may require 24/7 support.

Dennis P. Scanlon, PhD, faculty member and health services researcher at Penn State University, and associate editor of The American Journal of Managed Care, leads a discussion on diabetes and patient care management that is concentrated on patient behavior, patient motivation, and ultimately, patient adherence. He is joined by Paul Ciechanowski, MD, MPH; Todd Prewitt, MD, FAAFP; Trishan Panch, MD, MPH; and Ronal Tamler, MD, PhD, MBA, CDE.